EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC-ND 4.0

MRI ‐negative epilepsy: A systematic review and meta‐analysis

Ravnoor S Gill, Francesco Deleo iD, Boris Bernhardt, Samuel Wiebe iD, Neda Bernasconi iD, Andrea Bernasconi iD

Epilepsia · 2025-12 · 66 (12) · 4939-4949

DOI: 10.1111/epi.18616 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Epilepsia, online erschienen am 19.08.2025. Verfasst von Ravnoor S Gill und 5 weiteren Autor:innen. Beteiligte Einrichtung: Neuroimaging of Epilepsy Laboratory and Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Canad…. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Drug Resistant Epilepsy, Epilepsy. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, Epilepsy Canada, Brain Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Drug‐resistant focal epilepsy is commonly dichotomized based on magnetic resonance imaging (MRI) lesion visibility into positive (MRI‐pos) and negative (MRI‐neg). Yet, the criteria used to ascribe such categorization are variable. We used a systematic review and meta‐analysis to synthesize evidence for the designation of MRI‐neg status.

Methods

In accordance with Preferred Reporting Items for Systematic reviews and Meta‐Analyses (PRISMA) guidelines, the systematic review (1990–2025) across Embase, Cochrane, and Medline databases identified cohorts with MRI‐neg epilepsy. Unsupervised clustering stratified studies based on co‐occurrence of imaging modalities. Within identified classes, we assessed the consistency of reporting MRI parameters, rater expertise, post‐processing, and stereo–electroencephalography (SEEG). Meta‐analyses evaluated the effects of post‐processing on diagnostic yield and MRI‐neg status on post‐surgical outcome.

Results

We screened 2622 records and assessed the eligibility of 448 full‐text articles, 246 of which met the inclusion criteria for systematic review: 108 (44%) provided data only on MRI‐neg and 138 (56%) on mixed adult cohorts, for a total of 10.463 MRI‐neg and 7436 MRI‐pos patients. Compared to MRI‐pos, MRI‐neg patients underwent SEEG more frequently (75% vs 54%, p < 0.05), underwent surgery less frequently (73% vs 84%; odds ratio [OR] = 1.14, p < 0.001), and had less favorable outcomes (61% vs 72%, p < 0.05). Clustering identified three classes: MRI‐dominant , typified by consistent reporting of MRI parameters (ORs >3.11, p < 0.001), rater‐expertise (ORs >9.94, p < 0.001), and post‐processing (ORs >3.38, p < 0.03) , as opposed to Limited‐MRI (χ 2 = 41.08, p < 0.001); MRI‐and‐nuclear‐imaging class was typified by use of SEEG (ORs >3.33, p < 0.02). Meta‐analyses showed a 39% gain in diagnostic yield after post‐processing (11.10, 95% confidence interval [CI] 7.45–16.53) and a higher proportion of favorable surgical outcome in MRI‐pos compared to MRI‐neg (75% vs 58%; χ 2 = 19.10, p < 0.001). Time‐based sensitivity analyses did not affect results. Significance The designation of MRI‐neg is ambiguous, with most studies lacking details on imaging parameters and reader expertise. Given a 39% gain in diagnostic yield, MRI post‐processing should be performed systematically as part of a modern multimodal approach to epilepsy surgery before ascribing MRI‐neg status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Magnetic Resonance ImagingDrug Resistant EpilepsyEpilepsyHumansElectroencephalographyBrain

Stichwörter der Autor:innen

MRI‐negative epilepsymagnetic resonance imagingmeta‐analysisneuroimaging

Autor:innen und Institutionen

  • Neuroimaging of Epilepsy Laboratory and Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Canada.
  • Istituto Neurologico Carlo Besta, Milan, Italy.
  • Multimodal Imaging and Connectome Analysis Laboratory, Montreal Neurological Institute, McGill University, Montreal, Canada.
  • Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

ORCID-Profile: Francesco Deleo, Samuel Wiebe, Neda Bernasconi, Andrea Bernasconi

Förderung

  • Natural Sciences and Engineering Research Council of Canada
  • Epilepsy Canada
  • Brain Canada
  • Fonds de Recherche du Québec - Santé
  • Fondation Brain Canada

Zitieren

APA

Gill, R. S., Deleo, F., Bernhardt, B., Wiebe, S., Bernasconi, N., & Bernasconi, A. (2025). MRI ‐negative epilepsy: A systematic review and meta‐analysis. Epilepsia, 66(12), 4939-4949. https://doi.org/10.1111/epi.18616

Vancouver

Gill RS, Deleo F, Bernhardt B, Wiebe S, Bernasconi N, Bernasconi A. MRI ‐negative epilepsy: A systematic review and meta‐analysis. Epilepsia. 2025;66(12):4939-4949. doi:10.1111/epi.18616

BibTeX
@article{Gill2025,
  author = {Gill, Ravnoor S and Deleo, Francesco and Bernhardt, Boris and Wiebe, Samuel and Bernasconi, Neda and Bernasconi, Andrea},
  title = {MRI ‐negative epilepsy: A systematic review and meta‐analysis},
  journal = {Epilepsia},
  year = {2025},
  volume = {66},
  number = {12},
  pages = {4939--4949},
  doi = {10.1111/epi.18616}
}
Kostenlos starten →